DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Ajanta Pharma Limited — Outcome of Board Meeting

NSE 13 hrs ago·30 Oct 2026, 7:32 am

Ajanta Pharma

Ajanta Pharma has announced the financial results for the period ending September 30, 2026, following a board meeting. This update provides investors with the latest performance data for the company's ongoing fiscal year.

The release of these results is a key event for shareholders as it offers insight into the company's operational health. It highlights the company's ability to manage its business during this period and helps investors gauge its current financial trajectory.

Investors should pay close attention to the company's revenue growth, profit margins, and any commentary provided by management regarding future business prospects. This information will be crucial for assessing the stock's near-term performance.